GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NextCell Pharma AB (OSTO:NXTCL) » Definitions » Days Sales Outstanding

NextCell Pharma AB (OSTO:NXTCL) Days Sales Outstanding : 84.23 (As of Feb. 2024)


View and export this data going back to 2017. Start your Free Trial

What is NextCell Pharma AB Days Sales Outstanding?

NextCell Pharma AB's average Accounts Receivable for the three months ended in Feb. 2024 was kr2.15 Mil. NextCell Pharma AB's Revenue for the three months ended in Feb. 2024 was kr2.33 Mil. Hence, NextCell Pharma AB's Days Sales Outstanding for the three months ended in Feb. 2024 was 84.23.

The historical rank and industry rank for NextCell Pharma AB's Days Sales Outstanding or its related term are showing as below:

OSTO:NXTCL' s Days Sales Outstanding Range Over the Past 10 Years
Min: 42   Med: 72.88   Max: 122.14
Current: 56.91

During the past 9 years, NextCell Pharma AB's highest Days Sales Outstanding was 122.14. The lowest was 42.00. And the median was 72.88.

OSTO:NXTCL's Days Sales Outstanding is ranked better than
63.22% of 889 companies
in the Biotechnology industry
Industry Median: 72.66 vs OSTO:NXTCL: 56.91

NextCell Pharma AB's Days Sales Outstanding increased from Feb. 2023 (59.38) to Feb. 2024 (84.23).


NextCell Pharma AB Days Sales Outstanding Historical Data

The historical data trend for NextCell Pharma AB's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NextCell Pharma AB Days Sales Outstanding Chart

NextCell Pharma AB Annual Data
Trend Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only 42.00 60.41 103.15 103.45 74.46

NextCell Pharma AB Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 59.38 45.75 63.47 50.07 84.23

Competitive Comparison of NextCell Pharma AB's Days Sales Outstanding

For the Biotechnology subindustry, NextCell Pharma AB's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NextCell Pharma AB's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, NextCell Pharma AB's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where NextCell Pharma AB's Days Sales Outstanding falls into.



NextCell Pharma AB Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

NextCell Pharma AB's Days Sales Outstanding for the fiscal year that ended in Aug. 2023 is calculated as

Days Sales Outstanding (A: Aug. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Aug. 2022 ) + Accounts Receivable (A: Aug. 2023 )) / count ) / Revenue (A: Aug. 2023 )*Days in Period
=( (1.777 + 2.349) / 2 ) / 10.113*365
=2.063 / 10.113*365
=74.46

NextCell Pharma AB's Days Sales Outstanding for the quarter that ended in Feb. 2024 is calculated as:

Days Sales Outstanding (Q: Feb. 2024 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Nov. 2023 ) + Accounts Receivable (A: Feb. 2024 )) / count ) / Revenue (A: Feb. 2024 )*Days in Period
=( (2.311 + 1.998) / 2 ) / 2.334*365 / 4
=2.1545 / 2.334*365 / 4
=84.23

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


NextCell Pharma AB  (OSTO:NXTCL) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


NextCell Pharma AB Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of NextCell Pharma AB's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


NextCell Pharma AB (OSTO:NXTCL) Business Description

Traded in Other Exchanges
Address
Karolinska Institutet Science Park, Halsovagen 7, Huddinge, SWE, 14157
NextCell Pharma AB is a healthcare services provider. The company is engaged in the research of stem cell and is developing the candidate drug ProTrans for the treatment of diabetes and immunosuppression in kidney transplants.

NextCell Pharma AB (OSTO:NXTCL) Headlines

No Headlines